Cargando…
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
Non-resolving lung inflammation and Pseudomonas aeruginosa infections are the underlying cause of morbidity and mortality in cystic fibrosis (CF). The endogenous lipid mediator resolvin (Rv) D1 is a potent regulator of resolution, and its roles, actions, and therapeutic potential in CF are of intere...
Autores principales: | Isopi, Elisa, Mattoscio, Domenico, Codagnone, Marilina, Mari, Veronica Cecilia, Lamolinara, Alessia, Patruno, Sara, D’Aurora, Marco, Cianci, Eleonora, Nespoli, Annalisa, Franchi, Sara, Gatta, Valentina, Dubourdeau, Marc, Moretti, Paolo, Di Sabatino, Maria, Iezzi, Manuela, Romano, Mario, Recchiuti, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247852/ https://www.ncbi.nlm.nih.gov/pubmed/32528461 http://dx.doi.org/10.3389/fimmu.2020.00581 |
Ejemplares similares
-
Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
por: Recchiuti, Antonio, et al.
Publicado: (2021) -
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes
por: Mattoscio, Domenico, et al.
Publicado: (2021) -
382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021) -
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019) -
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A(4) receptor-dependent mechanisms of inflammation resolution and antimicrobial defense
por: Pierdomenico, Anna Maria, et al.
Publicado: (2017)